Davorin Kuchan

Founding Managing Partner at FreeRun Ventures

📍 United States🔄 Updated September 2026💼 11 investments📅 3 years investing🗓 Last invested Jul 2024
VC🌍 United States
11
Total investments
0
Early stage
1
Mid stage
6
Late stage
3y
Years active

Portfolio

9 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jul 2024
Subtle Medical is a medical imaging software company. Our goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose. We use the state-of-art proprietary deep learning AI algorithms to renovate the radiology workflow to deliver faster, safer and smarter imaging for imaging providers and the patients they serve.
Investor
Jul 2024
OpenSpace is the global leader in reality capture and AI-powered analytics for builders with projects of all sizes. With OpenSpace, you can easily capture a comprehensive visual record of your jobsite to verify work-in-place, simplify dispute resolution, and keep teams accountable. Our AI-powered computer vision and analytics tools give your team the visibility and insights they need with the power to compare BIM to as-built, automatically track progress, and stay on schedule. OpenSpace streamlines workflows for better communication, smarter resource allocation, and faster decisions. More than 250,000 users in 95 countries rely on OpenSpace to get the job done.
Investor
Jul 2024
Machina Labs unlocks manufacturing with AI & Robotics. Machinas Robotic Craftsman is introducing unseen flexibility and agility to the centuries-old manufacturing industry, enabling rapid iteration and innovation to design, engineering, and production. Machina helps leading companies quickly and affordably turn great ideas into reality.
mid stageManufacturing
Investor
Jul 2024
Our goal is to reduce opioid overdose mortality and injury by providing timely, autonomous, life-saving interventions.
Investor
Jul 2024
Correlia Biosystems develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules. The customizable PIXI​ platform opens up new biological questions for interrogation from less than two microliters of sample, with rapid results that allow for dynamic monitoring of protein expression profiles.
Investor
Jul 2024
Magnetic Insight introduces magnetic particle imaging, a groundbreaking imaging technology addressing todays clinical and translational research challenges. Magnetic Particle Imaging (MPI) is a new imaging technology unique from any other technology on the market. It is a functional imaging modality similar to PET, SPECT and optical where real time biological events can be monitored verses anatomical imaging such as computed tomography (CT) or magnetic resonance imaging (MRI). MPI offers the ability to target biomarkers, introduced into the cell and as a vascular tracer to support real-time blood flow and vascular architecture all with direct quantitation. Harnessing the magnetic properties of iron oxide nanoparticles, visualization and quantitation is specific, direct and unobstructed by tissue depth at exquisite sensitivity and with elegant resolution.
Investor
Jul 2024
RBC Signals is a leading provider of global satellite connectivity and data services, offering a cost-effective, flexible, and reliable dynamic spectrum leasing and Ground Station as a Service (GSaaS) platform.
Investor
Jul 2024
Our mission is to build the Covariant Brain, a universal AI to give robots the ability to see, reason and act on the world around them. Bringing AI from research in the lab to the infinite variability and constant change of our customer’s real-world operations requires new ideas, approaches and techniques. Success in the real world requires a team that represents that world: diversity of backgrounds, points of view, and experiences. Our common denominator: ambitious expectations, love of learning, empathy for those around us, and a team-first mindset.
Investor
Jul 2023
Metalenz, founded in 2016 is the first company to commercialize meta-optics. The company is backed by leading investors including 3M, Applied Ventures LLC, Intel Capital, M Ventures and TDK Ventures. The company has the exclusive worldwide license to the portfolio of foundational intellectual property relating to metasurfaces developed in the Capasso Lab at Harvard University and has more than 20 patents on innovations that simplify and improve optical devices across multiple markets
Experience · 15 entries
All (15)
Investments (11)
Founder (1)
2024
Investor
Jul 2024
Subtle Medical is a medical imaging software company. Our goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose. We use the state-of-art proprietary deep learning AI algorithms to renovate the radiology workflow to deliver faster, safer and smarter imaging for imaging providers and the patients they serve.
Investor
Jul 2024
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful. Follow us on Twitter: twitter.com/cytovale Subscribe to our newsletter: http://eepurl.com/huCdiH
Investor
Jul 2024
OpenSpace is the global leader in reality capture and AI-powered analytics for builders with projects of all sizes. With OpenSpace, you can easily capture a comprehensive visual record of your jobsite to verify work-in-place, simplify dispute resolution, and keep teams accountable. Our AI-powered computer vision and analytics tools give your team the visibility and insights they need with the power to compare BIM to as-built, automatically track progress, and stay on schedule. OpenSpace streamlines workflows for better communication, smarter resource allocation, and faster decisions. More than 250,000 users in 95 countries rely on OpenSpace to get the job done.
Investor
Jul 2024
Machina Labs unlocks manufacturing with AI & Robotics. Machinas Robotic Craftsman is introducing unseen flexibility and agility to the centuries-old manufacturing industry, enabling rapid iteration and innovation to design, engineering, and production. Machina helps leading companies quickly and affordably turn great ideas into reality.
mid stageManufacturing
Investor
Jul 2024
CORNAMI is focused on the deployment of intelligent computing in real-time environments. The company has developed a scalable, next-generation massively parallel processor architecture addressing the shift in computing needs for exploding dataset workloads in Machine Learning and Neural Network markets. CORNAMI delivers high performance anywhere and on any device at the lowest power and latency available.
Show all 15 entries ↓
Investment activity
2023–2024 · 11 investments
20231202410
Recent (last 2 years)Earlier